Sun Pharmaceuticals Industries (NSE:SUNPHARMA) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNPHARMA Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
92 GF Score
Price ₹1,902.40
GF Value ₹1,954.66
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Sun Pharmaceuticals Industries FFO?

FFO (Funds from operations) only applies to REITs.

NSE:SUNPHARMA
92GF Score
Sun Pharmaceuticals Industries Ltd NSE:SUNPHARMA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharmaceuticals Industries stock appears to be undervalued. The current stock price of ₹1,902.40 is trading 2.7% below its estimated GF Value™ of ₹1,954.66. GuruFocus considers Sun Pharmaceuticals Industries to be Fairly Valued.

Key valuation signals for NSE:SUNPHARMA:

  • FFO:
  • GF Value™: ₹1,954.66 vs. price of ₹1,902.40 (2.7% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the NSE:SUNPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sun Pharmaceuticals Industries Business Description

Other Exchanges 524715:India
Address Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's generic pharmaceutical manufacturing company. The company's substantial markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is majorly based in India.
92GF Score

Get the complete analysis for NSE:SUNPHARMA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,902.40
Price
₹1,954.66
GF Value